EUVIMEDEUVIMED entdecken
Crossref

Outcome of First Salvage Therapy in Patients With Chronic Lymphocytic Leukemia Relapsing After First-line Fludarabine, Cyclophosphamide, and Rituximab

Xavier Badoux, Constantine Tam, Susan Lerner, William Wierda, Michael J. Keating

Clinical Lymphoma and Myeloma · 2009-12 · 9 (6) · E39-E40

DOI: 10.3816/clm.2009.n.101 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Lymphoma and Myeloma, 2009-12. Verfasst von Xavier Badoux und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Badoux, X., Tam, C., Lerner, S., Wierda, W., & Keating, M. J. (2009). Outcome of First Salvage Therapy in Patients With Chronic Lymphocytic Leukemia Relapsing After First-line Fludarabine, Cyclophosphamide, and Rituximab. Clinical Lymphoma and Myeloma, 9(6), E39-E40. https://doi.org/10.3816/clm.2009.n.101

Vancouver

Badoux X, Tam C, Lerner S, Wierda W, Keating MJ. Outcome of First Salvage Therapy in Patients With Chronic Lymphocytic Leukemia Relapsing After First-line Fludarabine, Cyclophosphamide, and Rituximab. Clinical Lymphoma and Myeloma. 2009;9(6):E39-E40. doi:10.3816/clm.2009.n.101

BibTeX
@article{Badoux2009,
  author = {Badoux, Xavier and Tam, Constantine and Lerner, Susan and Wierda, William and Keating, Michael J.},
  title = {Outcome of First Salvage Therapy in Patients With Chronic Lymphocytic Leukemia Relapsing After First-line Fludarabine, Cyclophosphamide, and Rituximab},
  journal = {Clinical Lymphoma and Myeloma},
  year = {2009},
  volume = {9},
  number = {6},
  pages = {E39--E40},
  doi = {10.3816/clm.2009.n.101}
}
Kostenlos starten →